期刊文献+

临床护理路径在结核性胸膜炎患者中的应用 被引量:23

Application of clinical nursing pathway in the treatment of patients suffering Tuberculous Pleurisy
暂未订购
导出
摘要 目的探讨临床护理路径在结核性胸膜炎患者中的效果。方法随机抽取2010年1~12月我科室收治的结核性胸膜炎患者38例,采用临床护理路径进行护理,为观察组;另选取同期我科室38例结核性胸膜炎患者采取常规护理措施,设为对照组,比较两组患者的满意率及护理效果。结果两组护理质量合格率(χ2=3.878,P〈0.05)、满意率(χ2=4.790,P〈0.05)比较,差异有统计学意义。患者住院天数(t=7.012,P〈0.05)和住院费用(t=8.241,P〈0.05)比较,差异有统计学意义。结论临床护理路径应用于结核性胸膜炎患者,可以改进护理服务质量,提高患者的对护理服务的满意度,又能控制医疗成本、降低医疗费用,减轻患者负担,因此值得临床推广使用。 Objective To explore the application of clinical nursing pathway in the treatment of patients who suffered from tuberculous pleurisy.Methods A retrospective analysis was performed on 78 patients with tuberculous pleurisy in our hospital from Jan.2010 to Dec.2010.The patients were divided into two groups according to the way of nursing.The application and degree of satisfaction were compared between the two groups.Results The eligible rate of nursing quality(χ2=3.878,P0.05) and degree of satisfaction(χ2=4.790,P0.05) showed statistically significant difference between the two groups.The average length of hospital stay(t=7.012,P0.05) and the average cost(t=8.241,P0.05) also showed statistically significant difference between the two groups.Conclusion For patients who suffered from tuberculous pleurisy,the clinical nursing pathway can enhance the nursing quality of hospitals and the degree of satisfaction,decrease the medical cost and lighten the patients' burden,which thus has great value in clinical application.
出处 《海南医学》 CAS 2012年第8期145-147,共3页 Hainan Medical Journal
关键词 临床护理路径 结核性胸膜炎 护理 Clinical nursing pathway Tuberculous pleurisy Nursing
  • 相关文献

参考文献7

二级参考文献23

共引文献117

同被引文献117

  • 1邹卫,潘宴青,刘政呈,马国栋.胸膜纤维层剥脱术治疗慢性结核性脓胸71例[J].中华临床医师杂志(电子版),2011,5(22):6823-6825. 被引量:19
  • 2薛丽娟,施海涛,杨慧敏.肺结核并发结核性胸膜炎268例护理体会[J].求医问药(下半月),2013(1):125-126. 被引量:2
  • 3李凌江,郝伟,杨德森,张亚林,吴舸,罗友根,黄俊,张斌,刘解宁,廖巨福.社区人群生活质量研究──Ⅲ生活质量问卷(QOLI)的编制[J].中国心理卫生杂志,1995,9(5):227-231. 被引量:477
  • 4Diel R, Loddenkempor R, Meywald - Walter K,et al. Comparalqve per formance o{ tuberculin skin test, Quanti FERON - TB - Gold in tube assay,and T - Spot - TB test in contact investigations for tuberculosi[J]. Chest,2009,135(4):1010 - 1018.
  • 5Gottleb LD, Roer D,Jega K,et al. Clinical pathway for pneu- monia :development,implementation,and initial experience [J]. Best Pract Benchmarking Healthc, 1996,1 (5) : 262.
  • 6Estrada CA, Unterborn JN,Price J,et al. Judging the ef- fectiveness of clinical pathways for pneumonia: the role of risk adjustment [J]. Eft Clin Pract, 2000,3 (5) : 221.
  • 7Dendukuri N,Schiller I,Joseph L,et al. Bayesian meta analysis of the accuracy of a test for tuberculous pleuritis in the absence of a gold standard reference [J]. Biometrics, 2012,22 (5) : 1021-1027.
  • 8Connell TG,Ritz N,Paxton GA,et al. A three-way eom- pafison of tuberculin skin testing,Quanti FERON-TB Gold and T-SPOT TB in children [J]. PLoS One, 2008,3 (7) : 2624.
  • 9Raju B,Tung CF,Cheng D,et al. In situ activation of helper T cells in the lung [J]. Infect-immun,2001,69(8) :4790- 4798.
  • 10Atanackovic D, Block A,de Weerth A,et al. Characterization of effusion-infiltrating T cells: :benign versus malignant effusions [J]. Clin Cancer Res,2004,10 (8) :2600- 2608.

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部